Pre-Hour Trading Sees Chimerix (CMRX) Stock Spike On Buyout News
Following the news of a final purchase deal with Jazz Pharmaceuticals plc, shares of Chimerix, Inc. (NASDAQ: CMRX) saw a sharp increase. At $8.40 as of the most recent pre-market session, CMRX stock had up 69.35%. Strategic Acquisition for A Breakthrough Treatment According to the terms of the deal, Jazz Pharmaceuticals will pay $8.55 per …
Pre-Hour Trading Sees Chimerix (CMRX) Stock Spike On Buyout News Read More »